Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Rudy Li is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/19/2025 | STOK | Buy Now | Stoke Therapeutics | $8.24 | 191.09% | Rudy Li22% | $24 → $24 | Maintains | Buy | Get Alert |
| 02/21/2025 | PRTA | Buy Now | Prothena Corp | $12.79 | 212.74% | Rudy Li22% | $40 → $40 | Maintains | Buy | Get Alert |
| 02/19/2025 | STOK | Buy Now | Stoke Therapeutics | $8.24 | 191.09% | Rudy Li22% | $24 → $24 | Maintains | Buy | Get Alert |
| 12/20/2024 | PRTA | Buy Now | Prothena Corp | $12.79 | 212.74% | Rudy Li22% | → $40 | Initiates | → Buy | Get Alert |
| 12/20/2024 | STOK | Buy Now | Stoke Therapeutics | $8.24 | 191.09% | Rudy Li22% | → $24 | Initiates | → Buy | Get Alert |
| 12/20/2024 | MNMD | Buy Now | Mind Medicine | $6.57 | 204.41% | Rudy Li22% | → $20 | Initiates | → Buy | Get Alert |
| 04/15/2024 | MNMD | Buy Now | Mind Medicine | $6.57 | 204.41% | Rudy Li22% | → $20 | Initiates | → Outperform | Get Alert |
| 04/24/2023 | PRTA | Buy Now | Prothena Corp | $12.79 | 525.49% | Rudy Li22% | → $80 | Initiates | → Outperform | Get Alert |
